Objective: To determine diagnostic power of the symptoms and findings of patients with complaints of dizziness/balance disorder and to identify the syndromic diagnostic components for the benign paroxysmal positional vertigo (BPPV). Methods: A retrospective methodological study of 147 adult patients with dizziness/balance disorder visiting the Otorhinolaryngology Clinic between January and December 2014 was conducted. The symptoms, signs and laboratory test results of the patients in BPPV and non-BPPV groups were compared and analyzed through sensitivity, specificity, predictive values, likelihood ratios, post-test odds and probabilities, logistic regression analysis and ROC curve. The criterion indices having high post-test probability values were determined. Results: The most common three diagnoses were psychogenic vertigo (34.0%), peripheral vertigo of unknown origin (22.4%), and BPPV (16.3%). Five complaints and findings were found to have statistically significant diagnostic power: characteristic dizziness complaint, dizziness attacks lasting less than two minutes, dizziness being present for less than one week, supine roll and Dix-Hallpike test positivity. The post-test probability increased to 95.4% in patients with attacks lasting less than two minutes and dizziness lasting less than one week, when the Dix-Hallpike test was positive (triple-index positivity). According to the logistic regression model, positive result of the Dix-Hallpike test increased the probability of BPPV by 65.6 times. Accuracy of the model was 92.5%, with the area under the ROC curve of 0.891. Conclusions: Our study results have provided evidence basis for diagnostic power of the Dix Hallpike test and, to a lesser extent, of the supine roll test.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.